Elevance Health, Inc.
0HG8.L
London Stock Exchange418.16
USD
+6.61
- -
Elevance Health, Inc.
0HG8.L
(London Stock Exchange)
Recent
price
418.16
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Elevance Health Inc operates as a leading health benefits company in the United States, delivering integrated whole health solutions through its health plans, pharmacy services, and care delivery platforms. The company offers medical, dental, vision, behavioral health, long-term care, disability, and supplemental health insurance plans; Medicare Advantage, Medicare Supplement, Medicaid managed care, and employer-sponsored group coverage under brands including Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon; pharmacy benefit management through CarelonRx, encompassing claims processing, formulary management, and specialty pharmacy; and healthcare services such as specialty care enablement, utilization management, comprehensive care management, palliative care, virtual care, payment integrity, subrogation, clinical analytics, home health, post-acute care management, and durable medical equipment support via Carelon Services. Elevance Health serves over 118 million people across individual, employer, Medicare, Medicaid, and federal employee programs, with operations spanning 14 states and nationwide reach through affiliated entities. Founded in 2004 through the merger of Anthem Inc and WellPoint Health Networks and headquartered in Indianapolis, Indiana, the company rebranded from Anthem Inc in June 2022 to emphasize its evolution into a lifetime trusted health partner. Recent developments include the late 2024 acquisition of CareBridge to bolster home-based care capabilities; the January 2024 purchase of Paragon Healthcare for infusion services; the October 2024 acquisition of Kroger Specialty Pharmacy to enhance pharmacy offerings; the 2024 launch of Mosaic Health, a primary care joint venture with Clayton, Dubilier & Rice; and the early 2025 acquisition of Indiana University Health's insurance business, alongside ongoing expansion in Carelon's risk-based services and pharmacy segments that drove 33% year-over-year revenue growth in the division during third-quarter 2025.